Genetic and transcriptomic profiling of the epileptic network in patients with surgically treated seizures

手术治疗癫痫患者癫痫网络的遗传和转录组学分析

基本信息

项目摘要

PROJECT SUMMARY Medically-refractory epilepsy affects nearly 1 in 300 people, and for these patients resective brain surgery may be the only change for seizure freedom. Patients with abnormal neuroimaging findings which correlate with abnormal electroencephalography (EEG) activity have the best chance of seizure freedom after epilepsy surgery. In patients without clear neuroimaging abnormalities, stereo-EEG (sEEG) can localize an epileptic lesion and increase the success of a future resective surgery. sEEG is a minimally invasive procedure where electrodes are placed throughout, and within the brain to identify the seizure onset zone, peri-epileptic network and nonepileptic brain regions. After sEEG electrode removal, adherent cells can be used to evaluate genomic material in order to better understand the molecular processes that define an epileptic network. The overall objective of this application is to understand the mechanisms in the development of intractable epilepsy with the goal of developing a precision medicine approach to therapy. We will evaluate the genetics and transcriptomics of brain tissue resected in children and young adults with intractable epilepsy undergoing sEEG followed by resective surgery. Our central hypothesis that patients who develop intractable epilepsy have 1) somatic mutations in epilepsy-related molecular pathways which are not present in the germline and 2) unique gene expression profiles will be identified in epileptic tissue with dysregulation of known neurotransmitter and inflammatory pathways, compared to peri-epileptic and non-epileptic brain tissue.
项目摘要 医学难治性癫痫影响近1/300的人,对于这些患者, 这是唯一能让你摆脱癫痫的方法具有与以下相关的异常神经影像学结果的患者 异常脑电图(EEG)活动有最好的机会,癫痫发作后的自由 手术在没有明确的神经影像学异常的患者中,立体脑电图(sEEG)可以定位癫痫 并增加未来切除手术的成功率。sEEG是一种微创手术, 电极被放置在整个大脑中,并在大脑中识别癫痫发作区,癫痫周围网络 和非癫痫脑区。去除sEEG电极后,贴壁细胞可用于评估基因组 材料,以便更好地理解定义癫痫网络的分子过程。整体 本申请的目的是了解难治性癫痫的发展机制, 我们的目标是开发一种精确的医学治疗方法。我们将评估基因, 在接受难治性癫痫治疗的儿童和年轻成人中切除脑组织的转录组学 切除手术后的sEEG。我们的中心假设是患有难治性癫痫的患者 1)癫痫相关分子通路中的体细胞突变,其不存在于生殖系中, 2)独特的基因表达谱将被确定在癫痫组织与失调, 已知的神经递质和炎症通路,与癫痫周围和非癫痫脑组织相比。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Adam Lawrence Numis其他文献

Adam Lawrence Numis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Adam Lawrence Numis', 18)}}的其他基金

Genetic and transcriptomic profiling of the epileptic network in patients with surgically treated seizures
手术治疗癫痫患者癫痫网络的遗传和转录组学分析
  • 批准号:
    10528013
  • 财政年份:
    2022
  • 资助金额:
    $ 20.19万
  • 项目类别:
Evaluating the Role of Inflammation in Neonatal Epileptogenesis
评估炎症在新生儿癫痫发生中的作用
  • 批准号:
    10055785
  • 财政年份:
    2018
  • 资助金额:
    $ 20.19万
  • 项目类别:
Evaluating the Role of Inflammation in Neonatal Epileptogenesis
评估炎症在新生儿癫痫发生中的作用
  • 批准号:
    10524764
  • 财政年份:
    2018
  • 资助金额:
    $ 20.19万
  • 项目类别:
Evaluating the Role of Inflammation in Neonatal Epileptogenesis
评估炎症在新生儿癫痫发生中的作用
  • 批准号:
    10310461
  • 财政年份:
    2018
  • 资助金额:
    $ 20.19万
  • 项目类别:

相似海外基金

Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
  • 批准号:
    10004277
  • 财政年份:
    2020
  • 资助金额:
    $ 20.19万
  • 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
  • 批准号:
    10475298
  • 财政年份:
    2020
  • 资助金额:
    $ 20.19万
  • 项目类别:
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
  • 批准号:
    10013749
  • 财政年份:
    2020
  • 资助金额:
    $ 20.19万
  • 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
  • 批准号:
    10693904
  • 财政年份:
    2020
  • 资助金额:
    $ 20.19万
  • 项目类别:
Study on how anticonvulsants affect car driving
抗惊厥药如何影响汽车驾驶的研究
  • 批准号:
    20K17977
  • 财政年份:
    2020
  • 资助金额:
    $ 20.19万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
  • 批准号:
    10266034
  • 财政年份:
    2020
  • 资助金额:
    $ 20.19万
  • 项目类别:
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
  • 批准号:
    10475109
  • 财政年份:
    2020
  • 资助金额:
    $ 20.19万
  • 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
  • 批准号:
    10248384
  • 财政年份:
    2020
  • 资助金额:
    $ 20.19万
  • 项目类别:
Prevention of neuropathic pain by antidepressants and anticonvulsants: in vivo patch-clamp analysis
抗抑郁药和抗惊厥药预防神经性疼痛:体内膜片钳分析
  • 批准号:
    24592355
  • 财政年份:
    2012
  • 资助金额:
    $ 20.19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Anticonvulsants, ischemic seizures and regeneration in the immature brain
抗惊厥药、缺血性癫痫发作和未成熟大脑的再生
  • 批准号:
    8492175
  • 财政年份:
    2009
  • 资助金额:
    $ 20.19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了